Cargando…
The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age
Coronavirus disease 19 (COVID-19) is clinically less severe in children, even if the wide variety and degree of severity of symptoms reported in children pose a still-unresolved challenge for clinicians. We performed an in-depth analysis of the immunological profiles of 18 hospitalized SARS-CoV-2-in...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095251/ https://www.ncbi.nlm.nih.gov/pubmed/37047752 http://dx.doi.org/10.3390/ijms24076779 |
_version_ | 1785024038832177152 |
---|---|
author | Vanetti, Claudia Lampasona, Vito Stracuzzi, Marta Fenizia, Claudio Biasin, Mara Saulle, Irma Limanaqi, Fiona Abdelsalam, Ahmed Loretelli, Cristian Paradiso, Laura Longoni, Emma Barcellini, Lucia Piemonti, Lorenzo Marzinotto, Ilaria Dispinseri, Stefania Amendola, Antonella Fappani, Clara Tanzi, Elisabetta Clerici, Mario Salvatore Scarlatti, Gabriella Zuccotti, Gian Vincenzo Giacomet, Vania Trabattoni, Daria |
author_facet | Vanetti, Claudia Lampasona, Vito Stracuzzi, Marta Fenizia, Claudio Biasin, Mara Saulle, Irma Limanaqi, Fiona Abdelsalam, Ahmed Loretelli, Cristian Paradiso, Laura Longoni, Emma Barcellini, Lucia Piemonti, Lorenzo Marzinotto, Ilaria Dispinseri, Stefania Amendola, Antonella Fappani, Clara Tanzi, Elisabetta Clerici, Mario Salvatore Scarlatti, Gabriella Zuccotti, Gian Vincenzo Giacomet, Vania Trabattoni, Daria |
author_sort | Vanetti, Claudia |
collection | PubMed |
description | Coronavirus disease 19 (COVID-19) is clinically less severe in children, even if the wide variety and degree of severity of symptoms reported in children pose a still-unresolved challenge for clinicians. We performed an in-depth analysis of the immunological profiles of 18 hospitalized SARS-CoV-2-infected children, whose results were compared to those obtained from 13 age- and sex-matched healthy controls (HC). The patients were categorized as paucisymptomatic/moderate (55.6%) or severe/critical (44.5%) according to established diagnostic criteria and further stratified into the categories of infants (1–12 months), children (1–12 years), and adolescents (>12 years). We assessed SARS-CoV-2-specific RBD antibodies (Ab), neutralizing antibodies (nAb), and circulating cytokines/chemokines in the plasma, and the SARS-CoV-2-specific immune response was measured in PBMCs by gene expression and secretome analyses. Our results showed peculiar circulating cytokine/chemokine profiles among patients sharing a similar clinical phenotype. A cluster of patients consisting of infants with severe symptoms presented hyperinflammatory profiles, together with extremely polarized antibody profiles. In a second cluster consisting of paucisymptomatic patients, a less pronounced increase in the level of inflammatory cytokines, together with an association between the selected cytokines and humoral responses, was observed. A third cluster, again consisting of paucisymptomatic patients, showed a circulating cytokine/chemokine profile which overlapped with that of the HC. The SARS-CoV-2-stimulated production of pro-inflammatory proteins, T lymphocyte activation, and migration-specific proteins, were significantly increased in SARS-CoV-2-infected children compared to the HC. Our findings suggest that immune response activation in the course of SARS-CoV-2 infection in children is directly correlated with clinical severity and, to a lesser extent, age. |
format | Online Article Text |
id | pubmed-10095251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100952512023-04-13 The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age Vanetti, Claudia Lampasona, Vito Stracuzzi, Marta Fenizia, Claudio Biasin, Mara Saulle, Irma Limanaqi, Fiona Abdelsalam, Ahmed Loretelli, Cristian Paradiso, Laura Longoni, Emma Barcellini, Lucia Piemonti, Lorenzo Marzinotto, Ilaria Dispinseri, Stefania Amendola, Antonella Fappani, Clara Tanzi, Elisabetta Clerici, Mario Salvatore Scarlatti, Gabriella Zuccotti, Gian Vincenzo Giacomet, Vania Trabattoni, Daria Int J Mol Sci Article Coronavirus disease 19 (COVID-19) is clinically less severe in children, even if the wide variety and degree of severity of symptoms reported in children pose a still-unresolved challenge for clinicians. We performed an in-depth analysis of the immunological profiles of 18 hospitalized SARS-CoV-2-infected children, whose results were compared to those obtained from 13 age- and sex-matched healthy controls (HC). The patients were categorized as paucisymptomatic/moderate (55.6%) or severe/critical (44.5%) according to established diagnostic criteria and further stratified into the categories of infants (1–12 months), children (1–12 years), and adolescents (>12 years). We assessed SARS-CoV-2-specific RBD antibodies (Ab), neutralizing antibodies (nAb), and circulating cytokines/chemokines in the plasma, and the SARS-CoV-2-specific immune response was measured in PBMCs by gene expression and secretome analyses. Our results showed peculiar circulating cytokine/chemokine profiles among patients sharing a similar clinical phenotype. A cluster of patients consisting of infants with severe symptoms presented hyperinflammatory profiles, together with extremely polarized antibody profiles. In a second cluster consisting of paucisymptomatic patients, a less pronounced increase in the level of inflammatory cytokines, together with an association between the selected cytokines and humoral responses, was observed. A third cluster, again consisting of paucisymptomatic patients, showed a circulating cytokine/chemokine profile which overlapped with that of the HC. The SARS-CoV-2-stimulated production of pro-inflammatory proteins, T lymphocyte activation, and migration-specific proteins, were significantly increased in SARS-CoV-2-infected children compared to the HC. Our findings suggest that immune response activation in the course of SARS-CoV-2 infection in children is directly correlated with clinical severity and, to a lesser extent, age. MDPI 2023-04-05 /pmc/articles/PMC10095251/ /pubmed/37047752 http://dx.doi.org/10.3390/ijms24076779 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vanetti, Claudia Lampasona, Vito Stracuzzi, Marta Fenizia, Claudio Biasin, Mara Saulle, Irma Limanaqi, Fiona Abdelsalam, Ahmed Loretelli, Cristian Paradiso, Laura Longoni, Emma Barcellini, Lucia Piemonti, Lorenzo Marzinotto, Ilaria Dispinseri, Stefania Amendola, Antonella Fappani, Clara Tanzi, Elisabetta Clerici, Mario Salvatore Scarlatti, Gabriella Zuccotti, Gian Vincenzo Giacomet, Vania Trabattoni, Daria The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age |
title | The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age |
title_full | The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age |
title_fullStr | The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age |
title_full_unstemmed | The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age |
title_short | The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age |
title_sort | immunological profile of sars-cov-2 infection in children is linked to clinical severity and age |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095251/ https://www.ncbi.nlm.nih.gov/pubmed/37047752 http://dx.doi.org/10.3390/ijms24076779 |
work_keys_str_mv | AT vanetticlaudia theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT lampasonavito theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT stracuzzimarta theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT feniziaclaudio theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT biasinmara theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT saulleirma theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT limanaqifiona theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT abdelsalamahmed theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT loretellicristian theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT paradisolaura theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT longoniemma theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT barcellinilucia theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT piemontilorenzo theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT marzinottoilaria theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT dispinseristefania theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT amendolaantonella theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT fappaniclara theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT tanzielisabetta theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT clericimariosalvatore theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT scarlattigabriella theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT zuccottigianvincenzo theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT giacometvania theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT trabattonidaria theimmunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT vanetticlaudia immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT lampasonavito immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT stracuzzimarta immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT feniziaclaudio immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT biasinmara immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT saulleirma immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT limanaqifiona immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT abdelsalamahmed immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT loretellicristian immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT paradisolaura immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT longoniemma immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT barcellinilucia immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT piemontilorenzo immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT marzinottoilaria immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT dispinseristefania immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT amendolaantonella immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT fappaniclara immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT tanzielisabetta immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT clericimariosalvatore immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT scarlattigabriella immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT zuccottigianvincenzo immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT giacometvania immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage AT trabattonidaria immunologicalprofileofsarscov2infectioninchildrenislinkedtoclinicalseverityandage |